US Patent 7388020 Benzimidazol derivatives modulate chemokine receptors
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hans Lönn0
Svetlana Ivanova0
Tomas Eriksson0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+282 characters)
Article
Patent abstract
The invention provides compounds of general formula (I) wherein A, X, m, R1, N, R2, Z1, Z2, Q, R3, R4, R5, R6, R7, R8, t and R16 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07388020 Benzimidazol derivatives modulate chemokine receptors US Patent 7388020 Benzimidazol derivatives modulate chemokine receptors
Infobox
Patent Number
073880200
Patent Number
73880200
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073880200
Date of Patent
June 17, 2008
0Patent Application Number
104724120
Date Filed
March 18, 2002
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07388020 Benzimidazol derivatives modulate chemokine receptors
Infobox
Is a
Patent jurisdiction
Patent number
07388020
Date of patent
June 17, 2008
Patent application number
10472412
Date Filed
March 18, 2002
Patent primary examiner
Find more entities like US Patent 7388020 Benzimidazol derivatives modulate chemokine receptors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
